BONNEY MICHAEL W

CIK 000121901614 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001219016

Recent Transactions

50 trades

Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-18$450.00/sh−11,250→ 16,804 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-18$70.20/sh+11,250→ 28,054 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-08-18−11,250→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$268.56/sh−729→ 26,776 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$280.03/sh−432→ 21,323 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$273.16/sh−660→ 25,440 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$269.79/sh−245→ 26,531 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$271.68/sh−431→ 26,100 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$267.14/sh−549→ 27,505 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$277.16/sh−1,263→ 22,994 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$131.21/sh+11,250→ 28,054 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$278.01/sh−1,239→ 21,755 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$282.03/sh−802→ 20,149 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$282.81/sh−1,728→ 18,421 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$273.75/sh−882→ 24,558 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$275.63/sh−301→ 24,257 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-05-15−11,250→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$281.10/sh−372→ 20,951 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-15$283.83/sh−1,617→ 16,804 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-08+775→ 16,804 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-05-08+1,558→ 1,558 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-05-16+5,228→ 5,228 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-12-27$96.45/sh+30,000→ 46,029 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2023-12-27−30,000→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-12-27$195.00/sh−30,000→ 16,029 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-03$181.08/sh−300→ 22,177 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-03$187.04/sh−1,389→ 16,479 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-03$185.99/sh−1,714→ 17,868 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-03$187.71/sh−450→ 16,029 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-03$182.45/sh−500→ 21,677 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-03$184.89/sh−1,535→ 19,582 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-03$183.75/sh−560→ 21,117 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-08-02+22,477→ 22,477 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Restricted Stock Units
2023-08-02−22,477→ 0 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2023-05-18+3,454→ 3,454 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Restricted Stock Units
2021-08-02+22,477→ 22,477 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-07-15+4,032→ 4,032 total
Award
Kaleido Biosciences, Inc.
Stock Option (Right to Buy)
2021-06-30+15,000→ 15,000 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Deferred Share Units
2021-06-30+345.331→ 9,341.7 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2021-06-13−902→ 0 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2021-06-13+902→ 12,501 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2021-06-03−2,949→ 2,949 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2021-06-03+2,949→ 11,599 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2021-06-01+18,188→ 18,188 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Deferred Share Units
2021-03-31$63.13/sh+365.516→ 8,930.258 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Deferred Share Units
2021-02-01$62.21/sh+3,054.171→ 8,564.742 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Deferred Share Units
2020-12-31$62.03/sh+371.997→ 5,467.507 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Deferred Share Units
2020-09-30$60.29/sh+382.733→ 5,057.255 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2020-07-01+4,581→ 4,581 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Deferred Share Units
2020-06-30$58.80/sh+392.432→ 4,639.199 total

Companies

Recent Filings

Address

65 HAYDEN AVENUE

LEXINGTON, MA, 02421

View on SEC.gov